The funding follows backing from six investors, led by a £10.5m injection from the Scottish National Investment Bank.
"Orbex is one of only two space rocket manufacturers in the UK, and the only one to also operate its own spaceport. Our technology is pivotal in making the UK a hub for European orbital launch, and we are entering a critical phase of development. We are building a sustainable, cost-effective launch vehicle to compete with the best of Europe’s spaceflight manufacturers. This additional funding will support our goal to push on into an operational launch phase, and scale our business when the time comes."
Octopus Ventures led the seed financing round to help expand the company's data processing capabilities.
"Our end goal is to build an AGI with full perceptual abilities, which has boundless potential to assist with creativity. Our visual foundation model will be a leap forward in AI’s ability to deeply understand the physics of the world and replicate the essence of reality in the videos it generates. Such advancements lay the groundwork for AI that can understand, embrace, and enhance human storytelling."
The financing round was co-led by Greylock and DST Global Partners with participation from existing backers and angel investors.
"Lapse doesn't let you upload or edit in ways that other platforms encourage, Everyone on Lapse plays by the same rules, which creates a space where it's OK to share all moments, not just the glamorous."
The round was led by Octopus Ventures and Aenu to support the rollout of solar software for commercial real estate.
"Operational energy use of buildings accounts for ca. 30% of total global energy-related CO2 emissions. Metris Energy is in a unique position to provide end-to-end solar operations for commercial buildings, by offering everything from property selection and installation to tenant onboarding, billing and payments. This innovation offers property owners a compelling commercial opportunity, whilst also advancing the green energy revolution."
Octopus Ventures led the seed financing, with participation from Horizons Ventures, Verve Ventures, and Air Street Capital, to commercialise live cell imaging technology.
"University spin-outs like CellVoyant are at the heart of the UK’s thriving biotech ecosystem. CellVoyant sets a new standard in precision and reliability for predicting and controlling stem cell behaviour, which will make cell therapies more accessible to those who need them. We are thrilled to invest into a company that is transforming how patients can benefit from life-changing treatments."
